Insurance Implications for Individuals with a High Risk of Breast and Ovarian Cancer in Europe

P.J. Morrison, C.M. Steel, H.F.A. Vasen, D. Eccles, D.G.R. Evans, P. Møller, S. Hodgson, D. Stoppa-Lyonnet, J. ChangClaude, M. Caligo, E. Olah, N.E. Haites and N.C. Nevin Northern Ireland Regional Medical Genetics Centre, Belfast City Hospital Trust, Belfast, BT9 7AB, UK School of Biomedical Sciences, University of St. Andrews, Scotland, UK Foundation for the Detection of Hereditary Tumours, c/o University Hospital, Rijnsburgerweg 10, 2333 AA Leiden, The Netherlands Department of Human Genetics, Princess Ann Hospital, Southampton SO16 5YA, UK Department of Medical Genetics, St Mary’s Hospital, Manchester, UK Unit of Medical Genetics, The Norwegian radium Hospital, N-0310 Oslo, Norway Division of Medical and Molecular Genetics, Guy’s Hospital, London Bridge, London SE1 9RT, UK Unité de Génétique Oncologique Institut Curie Section Médicale 26, rue d’Ulm 75231 Paris Cedex 05 France Division of Epidemiology, German Cancer Research Centre, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany Institute of Pathology, University of Pisa, via Roma, 57,56126 Pisa, Italy